CDK4 and lung cancer: A study demonstrated that hyperoside exerts an inhibitory effect on the lung cancer cell line A549, with its mechanism involving the suppression of cyclin D1 (CCND1) and cyclin-dependent kinase 4/6 (CDK4/CDK6) expression.